- Tytuł:
- Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS-CoV-2 neutralizing monoclonal antibody ABBV-47D11 in patients with COVID-19.
- Autorzy:
- Źródło:
- Pharmacology Research & Perspectives. Feb2023, Vol. 11 Issue 1, p1-10. 10p.
Czasopismo naukowe